Johnson & Johnson Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Jul 3, 2022	Apr 3, 2022	Oct 3, 2021	Jul 4, 2021	Apr 4, 2021	Jan 3, 2021	Sep 27, 2020
Pharmaceutical	57.28B	56.96B	56.35B	55.67B	54.91B	54.76B	54.20B	53.52B	-	-	-	-	-	-	-
Pharmaceutical Growth	4.31%	4.03%	3.97%	4.01%	3.39%	4.18%	1.09%	0.44%	-	-	-	-	-	-	-
Medtech	32.06B	31.86B	31.34B	30.91B	30.74B	30.40B	29.50B	28.83B	-	-	-	-	-	-	-
Medtech Growth	4.28%	4.79%	6.23%	7.22%	10.03%	10.84%	7.24%	5.32%	-	-	-	-	-	-	-
Consumer Health	-	-	-	-	-	-	-	15.43B	-	-	-	-	-	-	-
Consumer Health Growth	-	-	-	-	-	-	-	3.31%	-	-	-	-	-	-	-

Revenue by Geography

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
US	50.99B	50.30B	49.61B	48.70B	49.58B	50.47B	50.41B	50.61B
US Growth	2.85%	-0.34%	-1.58%	-3.77%	2.05%	4.66%	5.60%	6.64%
Europe	20.16B	20.21B	21.11B	20.92B	21.60B	22.77B	22.48B	23.84B
Europe Growth	-6.67%	-11.23%	-6.10%	-12.23%	-9.87%	-7.28%	-8.71%	-1.52%
Asia Pacific and Africa	13.50B	13.59B	14.16B	14.14B	15.17B	16.08B	16.50B	17.24B
Asia Pacific and Africa Growth	-11.03%	-15.44%	-14.16%	-17.97%	-12.15%	-6.63%	-4.38%	-0.95%
Western Hemisphere Excluding US	4.69B	4.71B	5.12B	5.12B	5.62B	6.02B	6.03B	6.40B
Western Hemisphere Excluding US Growth	-16.65%	-21.64%	-15.07%	-19.94%	-8.82%	-0.38%	-0.71%	8.31%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.